Post Parker Institute Researchers Featured at Fourth International Immunotherapy Conference 2018 in New York #CICON18
Post Parker Institute for Cancer Immunotherapy Researchers Present Findings on Pancreatic Cancer, Tumor Vaccines and CAR-T at 2017 Society for Immunotherapy of Cancer Annual Meeting
Post The Parker Institute for Cancer Immunotherapy Expands its Network to Include More Rising Stars in Cancer Immunotherapy
Post Tessa Therapeutics and Parker Institute for Cancer Immunotherapy Enter into Strategic Alliance Agreement
Post Parker Institute for Cancer Immunotherapy Scientists Present at ASCO 2018 on Gene Editing in Cell Therapy, Novel Checkpoint Inhibitor Combinations and Other Advances in Immuno-Oncology
Post PsiOxus Therapeutics to Collaborate with the Parker Institute for Cancer Immunotherapy on Virus-Based Gene Therapy to Treat Solid Tumors
Post Empowering Tomorrow’s Great Minds in Cancer Research: The Parker Institute for Cancer Immunotherapy Awards up to $4.5 Million to Nine Early Career Researchers
Post The Parker Institute for Cancer Immunotherapy Appoints Immunotherapy Expert John Connolly as Chief Scientific Officer